Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 2,079 | 1,971 | 1,274 | 728 | 550 |
| Operating Income | -2,079 | -1,956 | -1,274 | -728 | -550 |
| Other Income | 785 | 2,586 | -253 | 0 | 0 |
| Pre-tax Income | -1,294 | 630 | -1,526 | -728 | -550 |
| Net Income Continuous | -1,294 | 630 | -1,526 | -728 | -550 |
| Net Income Discontinuous | -281 | N/A | N/A | N/A | N/A |
| Net Income | $-1,574 | $630 | $-1,526 | $-728 | $-550 |
| EPS Basic Total Ops | -1.20 | 2.40 | -3.40 | -1.80 | -1.40 |
| EPS Basic Continuous Ops | -1.12 | 2.38 | -3.41 | -1.76 | -1.38 |
| EPS Basic Discontinuous Ops | -0.24 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.20 | 2.40 | -3.40 | -1.80 | -1.40 |
| EPS Diluted Continuous Ops | -1.12 | 2.38 | -3.41 | -1.76 | -1.38 |
| EPS Diluted Discontinuous Ops | -0.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,079 | $-1,971 | $-1,274 | $-728 | $-550 |